CYBNY yields 2857.14% · PFE yields 6.13%● Live data
📍 CYBNY pulled ahead of the other in Year 1
Combined, CYBNY + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CYBNY + PFE for your $10,000?
Cyber Security 1 AB (publ), a cyber security company, provides cyber services and software solutions in Africa, the Middle East, Europe, and the United Arab Emirates. It operates through three segments: Distribution; Advisory Services; and MSSP/ Managed Services. The company also offers security, risk, and compliance solutions for payment, communication, network, and e-commerce security. In addition, it provides system security, GRC solutions, incident response, and forensics initial license and periodic maintenance agreements covering product updates and customer support; and professional advisory services, which includes legal compliance, installation, and integration of various cyber security system components. Further, the company offers MSSP/Managed services, such as data, network, and gateway securities; and managed compliance and SIEM services, incident response, and business continuity and cyber forensics. It serves public and private sector organizations, including financial, government, healthcare, retail, insurance, manufacturing, and hospitality. The company was formerly known as Cognosec AB (publ) and changed its name to Cyber Security 1 AB (publ) in July 2018. Cyber Security 1 AB (publ) was incorporated in 1970 and is headquartered in Stockholm, Sweden.
Full CYBNY Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.